Clinical Trials in Dallas

Showing 7161-7180 of 17,468 trials

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

NCT04950504

This study is a two-part Phase 1b/2a First-in-Human (FIH) randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, pharmacodynamics, and efficacy of multiple ascending doses of CNP-201 in Part A, with the goal of identifying a safe and tolerable dose level to be evaluated further in a larger number of subjects in Part B.

Peanut Allergy

COUR Pharmaceutical Development Company, Inc.9 participantsStarted Jun 2021

Scottsdale, Arizona, United States • Mountain View, California, United States • Rolling Hills Estates, California, United States +6 more locations

TERMINATEDPhase 2< 1 mile

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

NCT00931606

The purpose of this study is to evaluate the percentage of participants in each sotatercept dose regimen who achieve a hematopoietic response during the treatment period including up to 2 months after the last dose of sotatercept treatment of chemotherapy-induced anemia (CIA) in participants with metastatic breast cancer. Hematopoietic response was defined as an increase in hemoglobin concentration of ≥ 1 g/dL relative to baseline for 28 consecutive days during the treatment period including up to 2 months after the last dose of sotatercept in the absence of red blood cell (RBC) transfusion or treatment with an erythropoiesis-stimulating agent (ESA).

Chemotherapy Induced Anemia

Merck Sharp & Dohme LLC30 participantsStarted Jun 2009

Sedona, Arizona, United States • Hot Springs, Arkansas, United States • Beverly Hills, California, United States +32 more locations

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Find Trials by Condition in Dallas

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

Addressing Dementia Via Agitation-Centered Evaluation

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Subchondroplasty® Knee RCT

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Impact of Fever Prevention in Brain Injured Patients

A Study of BTX-1188 in Subjects With Advanced Malignancies

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Human Epilepsy Project 2: Resistant Focal Seizures Study

Multi-Center Pilot Study of truSculpt Device

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function